Abeona Therapeutics Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
21.33
|
|
Average Rating
|
4.33
|
|
# Strong Buys
|
2
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.75
|
-1.48
|
0.27
|
15.43%
|
|
2022-06-30
|
-1.87
|
-2.08
|
-0.21
|
-11.23%
|
|
2022-03-31
|
-2.37
|
-3.50
|
-1.13
|
-47.68%
|
|
2021-12-31
|
-3.67
|
-3.50
|
0.17
|
4.63%
|
|
2021-09-30
|
-4.06
|
-1.75
|
2.31
|
56.90%
|
|
2021-06-30
|
-4.12
|
-4.00
|
0.12
|
2.91%
|
|
2021-03-31
|
-4.67
|
-4.25
|
0.42
|
8.99%
|
|
2020-12-31
|
-2.50
|
-4.25
|
-1.75
|
-70.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-7.06
|
|
2021-12-31
|
-13.50
|
|
2020-12-31
|
-10.27
|
|
2019-12-31
|
-1.53
|
|
2018-12-31
|
-1.19
|
|
2017-12-31
|
-0.66
|
|
2016-12-31
|
-0.64
|
|
2015-12-31
|
-106.45
|
|
2013-12-31
|
77.52
|
|
2012-12-31
|
-377.84
|
|
2011-12-31
|
-129.21
|
|
2010-12-31
|
54.16
|
|
2009-12-31
|
-658.31
|
|
2008-12-31
|
-16487.07
|
|
2003-12-31
|
-5611.41
|
|
2001-12-31
|
-12724.06
|